Cases 1 - 5 of 5
Amarin Pharma, Inc. et al v. Hikma Pharmaceuticals USA Inc. et al
as 3:2020cv00421
Defendant:
Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Plaintiff:
Amarin Pharmaceuticals Ireland Limited and Amarin Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271
Alkermes Pharma Ireland Limited et al v. Luye Pharma Group LTD. et al
as 3:2019cv02227
Plaintiff:
Alkermes Pharma Ireland Limited, Alkermes Controlled Therapeutics, Inc. and Janssen Pharmaceuticals, Inc.
Defendant:
Luye Pharma (USA) LTD., Luye Pharma Group LTD., Nanjing Luye Pharmaceutical Co., LTD. and others
Petitioner:
Ajinomoto Althea, Inc.
Cause Of Action: 35 U.S.C. § 0271
Uniloc USA, Inc. et al v. Apple Inc.
as 3:2019cv01694
Defendant:
Apple Inc
Plaintiff:
UNILOC Luxembourg S.A. and Uniloc USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc. et al v. Watson Laboratories, Inc. et al
as 2:2019cv00837
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Watson Laboratories, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc.
Cause Of Action: 35 U.S.C. § 145
Fresenius Kabi USA, LLC v. BioQ Pharma Incorporated
as 3:2018cv01408
Plaintiff:
Fresenius Kabi USA, LLC
Defendant:
BioQ Pharma Incorporated
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
